All In MedTech

Device Trial Radar · NCT03636230

Virtual E-health System for Pacemakers

Virtual Integrated Reliable Transformative User-driven E-health System for Pacemakers

Last checked: Nov 20, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 848 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

848

Actual

Start

Sep 15, 2020

Primary completion

Apr 30, 2026

Study completion Jun 30, 2026

Sponsor

Lead sponsor
Ratika ParkashAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Cardiac Arrhythmia Network of Canada; Medtronic; Abbott
First posted
Aug 17, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

While remote monitoring (RM) technology is currently available and has permitted surveillance and device assessment from any patient location, the use has been inconsistent in Canada, where only 8500 out of a potential 120 000 patients with cardiac implantable electronic devices (CIEDs) are enrolled in this program. This technology is in widespread use worldwide for all CIEDs but in Canada, it is utilized primarily for implantable defibrillators, but not pacemakers. Whereas most of the trials were designed to evaluate the efficacy of RM in implantable cardioverter defibrillator (ICD) patients, in the pacemaker (PM) population, there has been work performed already to demonstrate an increase in detection of frequency of adverse clinical events and a reduction in reaction time to those events by RM. Based on all the available literature, it appears that RM benefits both patients and healthcare systems. Overall, studies have demonstrated that RM can be used safely in all device patient-populations, with the exception of pacemaker-dependent patients. There have been no studies that have evaluated RM only follow up, nor have there been any studies evaluating pacemaker-dependent patients. This study that will safely assess the use of RM only, with in-clinic visits when necessary, that uses the patient-centered electronic platform developed by the Cardiac Arrhythmia Network of Canada (CANet) to perform PM follow up safely, in a more cost-effective manner.

Conditions

  • Pacemaker

Interventions

  • Remote MonitoringDevice

    Remote Monitoring only + VIRTUES

  • Standard of careOther

    In-Clinic visits only

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to major adverse cardiac event (MACE)Time frame: 18 months
  2. Cost effectivenessTime frame: 18 months

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Foothills Hospital

    Calgary, Alberta, Canada

  • Victoria Cardiac Arrhythmia Trials

    Victoria, British Columbia, Canada

  • Memorial University of Newfoundland Hospital

    St. John's, Newfoundland and Labrador, Canada

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.